Microbicidal composition

Information

  • Patent Grant
  • 8895594
  • Patent Number
    8,895,594
  • Date Filed
    Wednesday, January 8, 2014
    10 years ago
  • Date Issued
    Tuesday, November 25, 2014
    9 years ago
Abstract
Synergistic microbicidal compositions containing N-methyl-1,2-benzisothiazolin-3-one.
Description

This invention relates to a synergistic combination of selected microbicides having greater activity than would be observed for the individual microbicides.


In some cases, commercial microbicides cannot provide effective control of microorganisms, even at high use concentrations, due to weak activity against certain types of microorganisms, e.g., those resistant to some microbicides, or due to aggressive environmental conditions. Combinations of different microbicides are sometimes used to provide overall control of microorganisms in a particular end use environment. For example, U.S. Pat. App. Pub. No. 2007/0078118 discloses synergistic combinations of N-methyl-1,2-benzisothiazolin-3-one (MBIT) with other biocides. However, there is a need for additional combinations of microbicides having enhanced activity against various strains of microorganisms to provide effective control of the microorganisms. Moreover, there is a need for combinations containing lower levels of individual microbicides for environmental and economic benefit. The problem addressed by this invention is to provide such additional combinations of microbicides.


STATEMENT OF THE INVENTION

The present invention is directed to a microbicidal composition comprising: (a) N-methyl-1,2-benzisothiazolin-3-one; and (b) at least one microbicide selected from among 2,2-dibromo-3-nitrilopropionamide, formaldehyde, 2-N-octyl-4-isothiazolin-3-one, propiconazole, tebuconazole, and a mixture of chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one.







DETAILED DESCRIPTION OF THE INVENTION

As used herein, the following terms have the designated definitions, unless the context clearly indicates otherwise. “MBIT” is N-methyl-1,2-benzisothiazolin-3-one. The term “microbicide” refers to a compound capable of killing, inhibiting the growth of or controlling the growth of microorganisms at a locus; microbicides include bactericides, fungicides and algaecides. The term “microorganism” includes, for example, fungi (such as yeast and mold), bacteria and algae. The term “locus” refers to an industrial system or product subject to contamination by microorganisms. The following abbreviations are used throughout the specification: ppm=parts per million by weight (weight/weight), mL=milliliter, ATCC=American Type Culture Collection, MBC=minimum biocidal concentration, and MIC=minimum inhibitory concentration. Unless otherwise specified, temperatures are in degrees centigrade (° C.), and references to percentages (%) are by weight. Amounts of organic microbicides are given on an active ingredient basis in ppm (w/w).


The compositions of the present invention unexpectedly have been found to provide enhanced microbicidal efficacy at a combined active ingredient level lower than that of the individual microbicides.


In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and 2,2-dibromo-3-nitrilopropionamide. Preferably, a weight ratio of 2,2-dibromo-3-nitrilopropionamide to N-methyl-1,2-benzisothiazolin-3-one is from 1:0.01 to 1:114, more preferably from 1:0.01 to 1:29, more preferably from 0.02 to 1:5.8.


In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and formaldehyde. Preferably, a weight ratio of formaldehyde to N-methyl-1,2-benzisothiazolin-3-one is from 1:0.0022 to 1:19, more preferably from 1:0.022 to 1:19, more preferably from 1:0.17 to 1:19.


In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and 2-N-octyl-4-isothiazolin-3-one. Preferably, a weight ratio of 2-N-octyl-4-isothiazolin-3-one to N-methyl-1,2-benzisothiazolin-3-one is from 1:0.02 to 1:882, more preferably from 1:0.13 to 1:882, more preferably from 1:0.13 to 1:150.


In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and propiconazole. Preferably, a weight ratio of propiconazole to N-methyl-1,2-benzisothiazolin-3-one is from 1:0.0022 to 1:6.8, more preferably from 1:0.075 to 1:6.8.


In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and tebuconazole. Preferably, a weight ratio of tebuconazole to N-methyl-1,2-benzisothiazolin-3-one is from 1:0.0033 to 1:46, more preferably from 1:0.15 to 1:46.


In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and a 3:1 mixture of chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one. Preferably, the mixture is about a 3:1 mixture, respectively. Preferably, a weight ratio of the mixture to N-methyl-1,2-benzisothiazolin-3-one is from 1:91 to 1:114.


The microbicides in the composition of this invention may be used “as is” or may first be formulated with a solvent or a solid carrier. Suitable solvents include, for example, water; glycols, such as ethylene glycol, propylene glycol, diethylene glycol, dipropylene glycol, polyethylene glycol, and polypropylene glycol; glycol ethers; alcohols, such as methanol, ethanol, propanol, phenethyl alcohol and phenoxypropanol; ketones, such as acetone and methyl ethyl ketone; esters, such as ethyl acetate, butyl acetate, triacetyl citrate, and glycerol triacetate; carbonates, such as propylene carbonate and dimethyl carbonate; and mixtures thereof. It is preferred that the solvent is selected from water, glycols, glycol ethers, esters and mixtures thereof. Suitable solid carriers include, for example, cyclodextrin, silicas, diatomaceous earth, waxes, cellulosic materials, alkali and alkaline earth (e.g., sodium, magnesium, potassium) metal salts (e.g., chloride, nitrate, bromide, sulfate) and charcoal.


When a microbicide component is formulated in a solvent, the formulation may optionally contain surfactants. When such formulations contain surfactants, they are generally in the form of emulsive concentrates, emulsions, microemulsive concentrates, or microemulsions. Emulsive concentrates form emulsions upon the addition of a sufficient amount of water. Microemulsive concentrates form microemulsions upon the addition of a sufficient amount of water. Such emulsive and microemulsive concentrates are generally well known in the art; it is preferred that such formulations are free of surfactants. U.S. Pat. No. 5,444,078 may be consulted for further general and specific details on the preparation of various microemulsions and microemulsive concentrates.


A microbicide component also can be formulated in the form of a dispersion. The solvent component of the dispersion can be an organic solvent or water, preferably water. Such dispersions can contain adjuvants, for example, co-solvents, thickeners, anti-freeze agents, dispersants, fillers, pigments, surfactants, biodispersants, sulfosuccinates, terpenes, furanones, polycations, stabilizers, scale inhibitors and anti-corrosion additives.


When both microbicides are each first formulated with a solvent, the solvent used for the first microbicide may be the same as or different from the solvent used to formulate the other commercial microbicide, although water is preferred for most industrial biocide applications. It is preferred that the two solvents are miscible.


Those skilled in the art will recognize that the microbicide components of the present invention may be added to a locus sequentially, simultaneously, or may be combined before being added to the locus. It is preferred that the first microbicide and the second microbicide component be added to a locus simultaneously or sequentially. When the microbicides are added simultaneously or sequentially, each individual component may contain adjuvants, such as, for example, solvent, thickeners, anti-freeze agents, colorants, sequestrants (such as ethylenediamine-tetraacetic acid, ethylenediaminedisuccinic acid, iminodisuccinic acid and salts thereof), dispersants, surfactants, biodispersants, sulfosuccinates, terpenes, furanones, polycations, stabilizers, scale inhibitors and anti-corrosion additives.


The microbicidal compositions of the present invention can be used to inhibit the growth of microorganisms or higher forms of aquatic life (such as protozoans, invertebrates, bryozoans, dinoflagellates, crustaceans, mollusks, etc.) by introducing a microbicidally effective amount of the compositions onto, into, or at a locus subject to microbial attack. Suitable loci include, for example: industrial process water; electrocoat deposition systems; cooling towers; air washers; gas scrubbers; mineral slurries; wastewater treatment; ornamental fountains; reverse osmosis filtration; ultrafiltration; ballast water; evaporative condensers; heat exchangers; pulp and paper processing fluids and additives; starch; plastics; emulsions; dispersions; paints; latices; coatings, such as varnishes; construction products, such as mastics, caulks, and sealants; construction adhesives, such as ceramic adhesives, carpet backing adhesives, and laminating adhesives; industrial or consumer adhesives; photographic chemicals; printing fluids; household products, such as bathroom and kitchen cleaners; cosmetics; toiletries; shampoos; soaps; detergents; industrial cleaners; floor polishes; laundry rinse water; metalworking fluids; conveyor lubricants; hydraulic fluids; leather and leather products; textiles; textile products; wood and wood products, such as plywood, chipboard, wallboard, flakeboard, laminated beams, oriented strandboard, hardboard, and particleboard; petroleum processing fluids; fuel; oilfield fluids, such as injection water, fracture fluids, and drilling muds; agriculture adjuvant preservation; surfactant preservation; medical devices; diagnostic reagent preservation; food preservation, such as plastic or paper food wrap; food, beverage, and industrial process pasteurizers; toilet bowls; recreational water; pools; and spas.


Preferably, the microbicidal compositions of the present invention are used to inhibit the growth of microorganisms at a locus selected from one or more of mineral slurries, pulp and paper processing fluids and additives, starch, emulsions, dispersions, paints, latices, coatings, construction adhesives, such as ceramic adhesives, carpet backing adhesives, photographic chemicals, printing fluids, household products such as bathroom and kitchen cleaners, cosmetics, toiletries, shampoos, soaps, detergents, industrial cleaners, floor polishes, laundry rinse water, metal working fluids, textile products, wood and wood products, agriculture adjuvant preservation, surfactant preservation, diagnostic reagent preservation, food preservation, and food, beverage, and industrial process pasteurizers.


The specific amount of the composition of this invention necessary to inhibit or control the growth of microorganisms and higher aquatic life forms in a locus depends upon the particular locus to be protected. Typically, the amount of the composition of the present invention to control the growth of microorganisms in a locus is sufficient if it provides from 0.1 to 1,000 ppm of the isothiazoline ingredient of the composition in the locus. It is preferred that the isothiazolone ingredients of the composition be present in the locus in an amount of at least 0.5 ppm, more preferably at least 4 ppm and most preferably at least 10 ppm. It is preferred that the isothiazolone ingredients of the composition be present in the locus in an amount of no more than 1000 ppm, more preferably no more than 500 ppm, and most preferably no more than 200 ppm.


EXAMPLES
Materials and Methods

The synergism of the combination of the present invention was demonstrated by testing a wide range of concentrations and ratios of the compounds.


One measure of synergism is the industrially accepted method described by Kull, F. C.; Eisman, P. C.; Sylwestrowicz, H. D. and Mayer, R. L., in Applied Microbiology 9:538-541 (1961), using the ratio determined by the formula:

Qa/QA+Qb/QB=Synergy Index (“SI”)

wherein:

    • QA=concentration of compound A (first component) in ppm, acting alone, which produced an end point (MIC of Compound A).
    • Qa=concentration of compound A in ppm, in the mixture, which produced an end point.
    • QB=concentration of compound B (second component) in ppm, acting alone, which produced an end point (MIC of Compound B).
    • Qb=concentration of compound B in ppm, in the mixture, which produced an end point.


When the sum of Qa/QA and Qb/QB is greater than one, antagonism is indicated. When the sum is equal to one, additivity is indicated, and when less than one, synergism is demonstrated. The lower the SI, the greater the synergy shown by that particular mixture. The minimum inhibitory concentration (MIC) of a microbicide is the lowest concentration tested under a specific set of conditions that prevents the growth of added microorganisms.


Synergy tests were conducted using standard microtiter plate assays with media designed for optimal growth of the test microorganism. Minimal salt medium supplemented with 0.2% glucose and 0.1% yeast extract (M9GY medium) was used for testing bacteria; Potato Dextrose Broth (PDB medium) was used for testing yeast and mold. In this method, a wide range of combinations of microbicides was tested by conducting high resolution MIC assays in the presence of various concentrations of MBIT. High resolution MICs were determined by adding varying amounts of microbicide to one column of a microtitre plate and doing subsequent ten-fold dilutions using an automated liquid handling system to obtain a series of endpoints ranging from 2 ppm to 10,000 ppm active ingredient.


The synergy of the combinations of the present invention was determined against a bacterium, Escherichia coli (E. coli—ATCC #8739), a yeast, Candida albicans (C. albicans—ATCC 10231), and a mold, Aspergillus niger (A. niger—ATCC 16404). The bacteria were used at a concentration of about 5×106 bacteria per mL and the yeast and mold at 5×105 fungi per mL. These microorganisms are representative of natural contaminants in many consumer and industrial applications. The plates were visually evaluated for microbial growth (turbidity) to determine the MIC after various incubation times at 25° C. (yeast and mold) or 30° C. (bacteria).


The test results for demonstration of synergy of the MBIT combinations of the present invention are shown below in Tables 1 through 6. In each test, Second Component (B) was MBIT and the First Component (A) was the other commercial microbicide. Each table shows the specific combinations of MBIT and the other component; results against the microorganisms tested with incubation times; the end-point activity in ppm measured by the MIC for MBIT alone (QB), for the other component alone (QA), for MBIT in the mixture (Qb) and for the other component in the mixture (Qa); the calculated SI value; and the range of synergistic ratios for each combination tested (other component/MBIT or A/B).














TABLE 1






Contact






Test Organisms
Time
Ca
Cb
S.I.
Ca:Cb





















A.
niger

3 days
1.275





ATCC # 16404


150






0.6
75
0.97
1:125.0000




0.9
75
1.21
1:83.3333 




0.9
1.2
0.71
1:1.3333 




1.275
1.2
1.01
1:0.9412 



C.
albicans

48 hrs
1.275





ATCC # 10231


30






1.275
1.86
1.06
1:1.4588 




1.275
0.94
1.03
1:0.7373 



72 hrs
1.275








30






1.275
1.86
1.06
1:1.4588 




1.275
0.94
1.03
1:0.7373 



Ps.
aeruginosa

24 hrs
1.275





ATCC#9027


100






1.275
6
1.06
1:4.7059 



48 hrs
1.275








175






0.6
100
1.04
1:166.6667



S.
aureus

48 hrs
0.9





ATCC#6538


60






0.2625
30
0.79
1:114.2857




0.33
30
0.87
1:90.9091 




0.6
30
1.17
1:50.0000 





Ca - ppm AI of CMI/MI (Chloro-2-methyl-4-isothiazolin-3-one/2-Methyl-4-isothiazolin-3-one)


Cb - ppm AI of MBIT (N-methyl-1,2-benzisothiazolin-3-one)


Ratio: Ca:Cb


















TABLE 2






Contact






Test Organisms
Time
Ca
Cb
S.I.
Ca:Cb





















A.
niger

3 days
42.5





ATCC # 16404


9.4






4.25
4.7
0.60
1:1.1059 




5.25
4.7
0.62
1:0.8952 




8.75
4.7
0.71
1:0.5371 




11
4.7
0.76
1:0.4273 




20
4.7
0.97
1:0.2350 




30
4.7
1.21
1:0.1567 




4.25
2.4
0.36
1:0.5647 




5.25
2.4
0.38
1:0.4571 




8.75
2.4
0.46
1:0.2743 




11
2.4
0.51
1:0.2182 




20
2.4
0.73
1:0.1200 




30
2.4
0.96
1:0.0800 




42.5
2.4
1.26
1:0.0565 




4.25
1.2
0.23
1:0.2824 




5.25
1.2
0.25
1:0.2286 




8.75
1.2
0.33
1:0.1371 




11
1.2
0.39
1:0.1091 




20
1.2
0.60
1:0.0600 




30
1.2
0.83
1:0.0400 




42.5
1.2
1.13
1:0.0282 



7 days
200








18.8






42.5
9.4
0.71
1:0.2212 




52.5
9.4
0.76
1:0.1790 




65
9.4
0.83
1:0.1446 




87.5
9.4
0.94
1:0.1074 




110
9.4
1.05
1:0.0855 




87.5
4.7
0.69
1:0.0537 




110
4.7
0.80
1:0.0427 




200
4.7
1.25
1:0.0235 




65
2.4
0.45
1:0.0369 




87.5
2.4
0.57
1:0.0274 




110
2.4
0.68
1:0.0218 




200
2.4
1.13
1:0.0120 




87.5
1.2
0.50
1:0.0137 




110
1.2
0.61
1:0.0109 




200
1.2
1.06
1:0.0060 



C.
albicans

48 hrs
44





ATCC # 10231


30






2.6
15
0.56
1:5.7692 




4.4
15
0.60
1:3.4091 




8
15
0.68
1:1.8750 




12
15
0.77
1:1.2500 




17
15
0.89
1:0.8824 




21
15
0.98
1:0.7143 




26
15
1.09
1:0.5769 




8
7.5
0.43
1:0.9375 




12
7.5
0.52
1:0.6250 




17
7.5
0.64
1:0.4412 




21
7.5
0.73
1:0.3571 




26
7.5
0.84
1:0.2885 




44
7.5
1.13
1:0.1705 




44
3.75
1.06
1:0.0852 




35
1.86
0.86
1:0.0531 




44
1.86
1.03
1:0.0423 




44
0.94
1.03
1:0.0214 



72 hrs
>44








30






4.4
15
0.6
1:3.4091 




8
15
0.68
1:1.8750 




12
15
0.77
1:1.2500 




17
15
0.89
1:0.8824 




21
15
0.98
1:0.7143 




26
15
1.09
1:0.5769 




8
7.5
0.43
1:0.9375 




12
7.5
0.52
1:0.6250 




17
7.5
0.64
1:0.4412 




21
7.5
0.73
1:0.3571 




26
7.5
0.84
1:0.2885 




44
7.5
1.25
1:0.1705 




35
1.86
0.86
1:0.0531 




44
1.86
1.06
1:0.0423 




44
0.94
1.03
1:0.0214 



Ps.
Aeruginosa

24 hrs
4.25





ATCC#9027


100






2
50
0.97
1:25.0000 




3
50
1.21
1:16.6667 




3
25
0.96
1:8.3333 




4.25
25
1.25
1:5.8824 




4.25
6
1.06
1:1.4118 



48 hrs
5.25








175






0.875
100
0.74
1:114.2857




1.1
100
0.78
1:90.9091 




2
100
0.95
1:50.0000 




3
100
1.14
1:33.3333 




5.25
12
1.07
1:2.2857 



S.
aureus

48 hrs
8.5





ATCC#6538


60






1.05
30
0.62
1:28.5714 




4
30
0.97
1:7.5000 




6
30
1.21
1:5.0000 




4
15
0.72
1:3.7500 




6
15
0.96
1:2.5000 




8.5
15
1.25
1:1.7647 




6
2
0.74
1:0.3333 




8.5
2
1.03
1:0.2353 




6
1
0.72
1:0.1667 




8.5
1
1.02
1:0.1176 





Ca - ppm AI of DBNPA (2,2-Dibromo-3-nitrilopropionamide)


Cb - ppm AI of MBIT(N-methyl-1,2-benzisothiazolin-3-one)


Ratio: Ca:Cb


















TABLE 3





Test
Contact






Organisms
Time
Ca
Cb
S.I.
Ca:Cb





















A.
niger

3 days
200





ATCC # 16404


75






2
37.5
0.51
1:18.7500




5.25
37.5
0.53
1:7.1429 




8.75
37.5
0.54
1:4.2857 




11
37.5
0.56
1:3.4091 




20
37.5
0.60
1:1.8750 




30
37.5
0.65
1:1.2500 




42.5
37.5
0.71
1:0.8824 




52.5
37.5
0.76
1:0.7143 




65
37.5
0.83
1:0.5769 




87.5
37.5
0.94
1:0.4286 




110
37.5
1.05
1:0.3409 




42.5
18.8
0.46
1:0.4424 




52.5
18.8
0.51
1:0.3581 




65
18.8
0.58
1:0.2892 




87.5
18.8
0.69
1:0.2149 




110
18.8
0.80
1:0.1709 




200
18.8
1.25
1:0.0940 




65
9.4
0.45
1:0.1446 




87.5
9.4
0.56
1:0.1074 




110
9.4
0.68
1:0.0855 




200
9.4
1.13
1:0.0470 




87.5
4.7
0.50
1:0.0537 




110
4.7
0.61
1:0.0427 




200
4.7
1.06
1:0.0235 




110
2.4
0.58
1:0.0218 




200
2.4
1.03
1:0.0120 




200
1.2
1.02
1:0.0060 



7 days
425








150






65
75
0.65
1:1.1538 




87.5
75
0.71
1:0.8571 




110
75
0.76
1:0.6818 




200
75
0.97
1:0.3750 




300
75
1.21
1:0.2500 




300
37.5
0.96
1:0.1250 




425
37.5
1.25
1:0.0882 




200
18.8
0.6
1:0.0940 




300
18.8
0.83
1:0.0627 




425
18.8
1.13
1:0.0442 




425
9.4
1.06
1:0.0221 




425
4.7
1.03
1:0.0111 




300
2.4
0.72
1:0.0080 




425
2.4
1.02
1:0.0056 




300
1.2
0.71
1:0.0040 




425
1.2
1.01
1:0.0028 



C.
albicans

48 hrs
425





ATCC # 10231


30






87.5
15
0.71
1:0.1714 




110
15
0.76
1:0.1364 




200
15
0.97
1:0.0750 




300
15
1.21
1:0.0500 




875
7.5
2.31
1:0.0086 




300
3.75
0.83
1:0.0125 




425
3.75
1.13
1:0.0088 




300
1.86
0.77
1:0.0062 




425
1.86
1.06
1:0.0044 




425
0.94
1.03
1:0.0022 



72 hrs
525








30






110
15
0.71
1:0.1364 




200
15
0.88
1:0.0750 




300
15
1.07
1:0.0500 




300
3.75
0.70
1:0.0125 




425
3.75
0.93
1:0.0088 




525
3.75
1.13
1:0.0071 




425
1.86
0.87
1:0.0044 




525
1.86
1.06
1:0.0035 




425
0.94
0.84
1:0.0022 




525
0.94
1.03
1:0.0018 



Ps.
aeruginosa

24 hrs
15





ATCC#9027


100






15
6
1.06
1:0.4000 



48 hrs
26.25








175






10
100
0.95
1:10.0000




15
100
1.14
1:6.6667 




15
50
0.86
1:3.3333 




21.25
50
1.10
1:2.3529 




21.25
25
0.95
1:1.1765 




26.25
25
1.14
1:0.9524 




21.25
12
0.88
1:0.5647 




26.25
12
1.07
1:0.4571 




21.25
6
0.84
1:0.2824 




26.25
6
1.03
1:0.2286 



S.
aureus

24 hrs
30





ATCC#6538


60






3
30
0.60
1:10.0000




5.25
30
0.68
1:5.7143 




11
30
0.87
1:2.7273 




20
30
1.17
1:1.5000 




20
15
0.92
1:0.7500 




30
15
1.25
1:0.5000 




30
3
1.05
1:0.1000 




30
2
1.03
1:0.0667 




30
1
1.02
1:0.0333 



48 hrs
30








60






5.25
30
0.68
1:5.7143 




11
30
0.87
1:2.7273 




20
30
1.17
1:1.5000 




20
15
0.92
1:0.7500 




30
3
1.05
1:0.1000 




30
2
1.03
1:0.0667 




30
1
1.02
1:0.0333 





Ca - ppm AI of HCHO (Formaldehyde)


Cb - ppm AI of MBIT(N-methyl-1,2-benzisothiazolin-3-one)


Ratio: Ca:Cb


















TABLE 4





Test
Contact






Organisms
Time
Ca
Cb
S.I.
Ca:Cb





















A.
niger

3 days
0.65





ATCC # 16404


75






0.0425
37.5
0.57
1:882.3529




0.065
37.5
0.60
1:576.9231




0.11
37.5
0.67
1:340.9091




0.2
37.5
0.81
1:187.5000




0.3
37.5
0.96
1:125.0000




0.425
37.5
1.15
1:88.2353 




0.525
18.8
1.06
1:35.8095 




0.525
9.4
0.93
1:17.9048 




0.65
9.4
1.13
1:14.4615 




0.525
4.7
0.87
1:8.9524 




0.65
4.7
1.06
1:7.2308 




0.65
2.4
1.03
1:3.6923 




0.65
1.2
1.02
1:1.8462 



7 days
8.75








150






0.525
150
1.06
1:285.7143




1.1
75
0.63
1:68.1818 




2
75
0.73
1:37.5000 




3
75
0.84
1:25.0000 




4.25
75
0.99
1:17.6471 




5.25
75
1.10
1:14.2857 




2
37.5
0.48
1:18.7500 




3
37.5
0.59
1:12.5000 




4.25
37.5
0.74
1:8.8235 




5.25
37.5
0.85
1:7.1429 




6.5
37.5
0.99
1:5.7692 




8.75
37.5
1.25
1:4.2857 




0.875
18.8
0.23
1:21.4857 




1.1
18.8
0.25
1:17.0909 




2
18.8
0.35
1:9.4000 




3
18.8
0.47
1:6.2667 




4.25
18.8
0.61
1:4.4235 




6.5
18.8
0.87
1:2.8923 




8.75
18.8
1.13
1:2.1486 




2
9.4
0.29
1:4.7000 




3
9.4
0.41
1:3.1333 




4.25
9.4
0.55
1:2.2118 




5.25
9.4
0.66
1:1.7905 




6.5
9.4
0.81
1:1.4462 




8.75
9.4
1.06
1:1.0743 




2
4.7
0.26
1:2.3500 




3
4.7
0.37
1:1.5667 




4.25
4.7
0.52
1:1.1059 




5.25
4.7
0.63
1:0.8952 




6.5
4.7
0.77
1:0.7231 




8.75
4.7
1.03
1:0.5371 




5.25
2.4
0.62
1:0.4571 




6.5
2.4
0.76
1:0.3692 




8.75
2.4
1.02
1:0.2743 




5.25
1.2
0.61
1:0.2286 




6.5
1.2
0.75
1:0.1846 




8.75
1.2
1.01
1:0.1371 



C.
albicans

48 hrs
3.25





ATCC # 10231


30






2.625
7.5
1.06
1:2.8571 




2.625
3.75
0.93
1:1.4286 




3.25
3.75
1.13
1:1.1538 




3.25
1.86
1.06
1:0.5723 




3.25
0.94
1.03
1:0.2892 



72 hrs
3.25








30






3.25
1.86
1.06
1:0.5723 




3.25
0.94
1.03
1:0.2892 



Ps.
aeruginosa

24 hrs
650





ATCC#9027


100






525
25
1.06
1:0.0476 




525
12
0.93
1:0.0229 




650
12
1.12
1:0.0185 




650
6
1.06
1:0.0092 



48 hrs
650








175






200
100
0.88
1:0.5000 




300
100
1.03
1:0.3333 




525
50
1.09
1:0.0952 




525
25
0.95
1:0.0476 




650
25
1.14
1:0.0385 




650
12
1.07
1:0.0185 




650
6
1.03
1:0.0092 



S.
aureus

24 hrs
30





ATCC#6538


30






3
15
0.60
1:5.0000 




5.25
15
0.68
1:2.8571 




6.5
15
0.72
1:2.3077 




8.75
15
0.79
1:1.7143 




11
15
0.87
1:1.3636 




20
15
1.17
1:0.7500 




20
7.5
0.92
1:0.3750 




30
7.5
1.25
1:0.2500 




30
2
1.07
1:0.0667 




30
1
1.03
1:0.0333 



48 hrs
200








60






0.2
30
0.50
1:150.0000




2
30
0.51
1:15.0000 




20
30
0.60
1:1.5000 




30
30
0.65
1:1.0000 




42.5
30
0.71
1:0.7059 




52.5
30
0.76
1:0.5714 




87.5
30
0.94
1:0.3429 




110
30
1.05
1:0.2727 




4.25
15
0.27
1:3.5294 




2
15
0.26
1:7.5000 




20
15
0.35
1:0.7500 




30
15
0.40
1:0.5000 




42.5
15
0.46
1:0.3529 




52.5
15
0.51
1:0.2857 




87.5
15
0.69
1:0.1714 




110
15
0.80
1:0.1364 




200
15
1.25
1:0.0750 




20
7.5
0.23
1:0.3750 




30
7.5
0.28
1:0.2500 




42.5
7.5
0.34
1:0.1765 




52.5
7.5
0.39
1:0.1429 




87.5
7.5
0.56
1:0.0857 




110
7.5
0.68
1:0.0682 




200
7.5
1.13
1:0.0375 




87.5
3
0.49
1:0.0343 




110
3
0.6
1:0.0273 




200
3
1.05
1:0.0150 




200
2
1.03
1:0.0100 




200
1
1.02
1:0.0050 





Ca - ppm AI of OIT (2-N-octyl-4-isothiazolin-3-one)


Cb - ppm AI of MBIT(N-methyl-1,2-benzisothiazolin-3-one)


Ratio: Ca:Cb




















TABLE 5







Test
Contact







Organisms
Time
Ca
Cb
S.I.
Ca:Cb
























A.
niger

3 days
52.5






ATCC # 16404


37.5







6.5
18.8
0.63
1:2.8923





11
18.8
0.71
1:1.7091





20
18.8
0.88
1:0.9400





30
18.8
1.07
1:0.6267





52.5
2.4
1.06
1:0.0457





52.5
1.2
1.03
1:0.0229




7 days
87.5









150







11
75
0.63
1:6.8182





20
75
0.73
1:3.7500





30
75
0.84
1:2.5000





42.5
75
0.99
1:1.7647





52.5
75
1.10
1:1.4286





42.5
37.5
0.74
1:0.8824





52.5
37.5
0.85
1:0.7143





65
37.5
0.99
1:0.5769





52.5
18.8
0.73
1:0.3581





65
18.8
0.87
1:0.2892





87.5
18.8
1.13
1:0.2149





87.5
9.6
1.06
1:0.1097





87.5
4.7
1.03
1:0.0537





87.5
2.4
1.02
1:0.0274





87.5
1.2
1.01
1:0.0137




C.
albicans

48 hrs
525






ATCC # 10231


30







8.75
15
0.52
1:1.7143





20
15
0.54
1:0.7500





42.5
15
0.58
1:0.3529





65
15
0.62
1:0.2308





110
15
0.71
1:0.1364





200
15
0.88
1:0.0750





300
15
1.07
1:0.0500





65
7.5
0.37
1:0.1154





110
7.5
0.46
1:0.0682





200
7.5
0.63
1:0.0375





300
7.5
0.82
1:0.0250





425
7.5
1.06
1:0.0176





200
3.75
0.51
1:0.0188





300
3.75
0.70
1:0.0125





425
3.75
0.93
1:0.0088





525
3.75
1.13
1:0.0071





200
1.86
0.44
1:0.0093





300
1.86
0.63
1:0.0062





425
1.86
0.87
1:0.0044





525
1.86
1.06
1:0.0035





425
0.94
0.84
1:0.0022





525
0.94
1.03
1:0.0018




72 hrs
525









30







8.75
15
0.52
1:1.7143





20
15
0.54
1:0.7500





42.5
15
0.58
1:0.3529





65
15
0.62
1:0.2308





110
15
0.71
1:0.1364





200
15
0.88
1:0.0750





300
15
1.07
1:0.0500





65
7.5
0.37
1:0.1154





110
7.5
0.46
1:0.0682





200
7.5
0.63
1:0.0375





300
7.5
0.82
1:0.0250





425
7.5
1.06
1:0.0176





200
3.75
0.51
1:0.0188





300
3.75
0.70
1:0.0125





425
3.75
0.93
1:0.0088





525
3.75
1.13
1:0.0071





200
1.86
0.44
1:0.0093





300
1.86
0.63
1:0.0062





425
1.86
0.87
1:0.0044





525
1.86
1.06
1:0.0035





425
0.94
0.84
1:0.0022





525
0.94
1.03
1:0.0018




Ps.
Aeruginosa

24 hrs
875






ATCC#9027


100







650
25
0.99
1:0.0385





875
6
1.06
1:0.0069




48 hrs
875









175







875
12
1.07
1:0.0137





875
6
1.03
1:0.0069




S.aureus

24 hrs
1100






ATCC#6538


30







200
15
0.68
1:0.0750





300
15
0.77
1:0.0500





425
15
0.89
1:0.0353





525
15
0.98
1:0.0286





650
15
1.09
1:0.0231





875
7.5
1.05
1:0.0086





875
3
0.90
1:0.0034





1100
3
1.1
1:0.0027





1100
2
1.07
1:0.0018





1100
1
1.03
1:0.0009




48 hrs
1100









60







200
15
0.43
1:0.0750





300
15
0.52
1:0.0500





425
15
0.64
1:0.0353





525
15
0.73
1:0.0286





650
15
0.84
1:0.0231





875
15
1.05
1:0.0171





875
7.5
0.92
1:0.0086





1100
7.5
1.13
1:0.0068





875
3
0.85
1:0.0034





1100
3
1.05
1:0.0027





1100
2
1.03
1:0.0018





1100
1
1.02
1:0.0009







Ca - ppm AI of Propiconazole (1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole)



Cb - ppm AI of MBIT(N-methyl-1,2-benzisothiazolin-3-one



Ratio: Ca:Cb


















TABLE: 6





Test
Contact






Organisms
Time
Ca
Cb
S.I.
Ca:Cb





















A.
niger

3 days
4.25





ATCC # 16404


37.5






1.1
18.8
0.76
1:17.0909




2
18.8
0.97
1:9.4000 



7 days
11








150






11
2.4
1.02
1:0.2182 




11
1.2
1.01
1:0.1091 



C.
albicans

48 hrs
110





ATCC # 10231


30






42.5
15
0.89
1:0.3529 




52.5
15
0.98
1:0.2857 




65
15
1.09
1:0.2308 




87.5
7.5
1.05
1:0.0857 




110
1.86
1.06
1:0.0169 




110
0.94
1.03
1:0.0085 



72 hrs
110








30






42.5
15
0.89
1:0.3529 




52.5
15
0.98
1:0.2857 




65
15
1.09
1:0.2308 




87.5
7.5
1.05
1:0.0857 




110
1.86
1.06
1:0.0169 




110
0.94
1.03
1:0.0085 



Ps.
aeruginosa

24 hrs
875





ATCC#9027


100






650
25
0.99
1:0.0385 




875
6
1.06
1:0.0069 



48 hrs
1100








175






875
50
1.08
1:0.0571 




875
25
0.94
1:0.0286 




1100
25
1.14
1:0.0227 




1100
12
1.07
1:0.0109 




1100
6
1.03
1:0.0055 



S.
aureus

24 hrs
300





ATCC#6538


30






87.5
15
0.79
1:0.1714 




110
15
0.87
1:0.1364 




200
15
1.17
1:0.0750 




200
7.5
0.92
1:0.0375 




300
7.5
1.25
1:0.0250 




200
3
0.77
1:0.0150 




200
2
0.73
1:0.0100 




300
2
1.07
1:0.0067 




200
1
0.70
1:0.0050 




300
1
1.03
1:0.0033 



48 hrs
425








60






0.65
30
0.50
1:46.1538




2
30
0.50
1:15.0000




4.25
30
0.51
1:7.0588 




6.5
30
0.52
1:4.6154 




11
30
0.53
1:2.7273 




20
30
0.55
1:1.5000 




30
30
0.57
1:1.0000 




42.5
30
0.60
1:0.7059 




52.5
30
0.62
1:0.5714 




65
30
0.65
1:0.4615 




87.5
30
0.71
1:0.3429 




110
30
0.76
1:0.2727 




200
30
0.97
1:0.1500 




300
30
1.21
1:0.1000 




87.5
15
0.46
1:0.1714 




110
15
0.51
1:0.1364 




200
15
0.72
1:0.0750 




300
15
0.96
1:0.0500 




425
15
1.25
1:0.0353 




200
7.5
0.6
1:0.0375 




300
7.5
0.83
1:0.0250 




425
7.5
1.13
1:0.0176 




200
3
0.52
1:0.0150 




300
3
0.76
1:0.0100 




425
3
1.05
1:0.0071 




200
2
0.5
1:0.0100 




300
2
0.74
1:0.0067 




425
2
1.03
1:0.0047 




200
1
0.49
1:0.0050 




300
1
0.72
1:0.0033 




425
1
1.02
1:0.0024 





Ca - ppm AI of Tebuconazole (alpha-[2-(4-chlorophenyl]ethyl]-alpha-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol)


Cb - ppm AI of MBIT (N-methyl-1,2-benzisothiazolin-3-one)


Ratio: Ca:Cb





Claims
  • 1. A microbicidal composition comprising: (a) N-methyl-1,2-benzisothiazolin-3-one; and(b) propiconazole; and a ratio of propiconazole to N-methyl-1,2-benzisothiazolin-3-one is from 1:0.0022 to 1:0.0125 or from 1:0.0188 to 1:6.8; wherein the microbicidal composition is synergistic.
US Referenced Citations (5)
Number Name Date Kind
6576629 Oppong et al. Jun 2003 B1
6726937 Imai Apr 2004 B2
20040198785 Heer et al. Oct 2004 A1
20050197366 Chia et al. Sep 2005 A1
20070078118 Levy et al. Apr 2007 A1
Foreign Referenced Citations (1)
Number Date Country
1531431 Nov 1978 GB
Related Publications (1)
Number Date Country
20140121252 A1 May 2014 US
Provisional Applications (1)
Number Date Country
60936564 Jun 2007 US
Divisions (1)
Number Date Country
Parent 12214425 Jun 2008 US
Child 14150031 US